Related Experiment Video
Updated: Jun 25, 2025

00:06
Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
7.0K
Postbiotics as Metabolites and Their Biotherapeutic Potential
1Center of Clinical and Preclinical Research MEDIPARK, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Trieda SNP 1, 040 11 Košice, Slovakia.
International Journal of Molecular Sciences
|May 25, 2024
Summary
Postbiotics, derived from microorganisms, offer promising therapeutic potential for metabolic disorders. Further research is essential to identify new postbiotics and understand their mechanisms for immune and gut health.
Area of Science:
- Microbiology and Immunology
- Metabolic Health
- Gut Microbiota Research
Background:
- Postbiotics represent a promising area for therapeutic development.
- Their potential in modulating immune responses and gut microbiota is underappreciated.
- Natural compounds from microorganisms warrant further investigation.
Purpose of the Study:
- To review the current knowledge on postbiotics.
- To highlight their potential role in combating metabolic disorders.
- To guide future research in identifying and characterizing new postbiotics.
Main Methods:
- Literature review of existing studies on postbiotics.
- Analysis of potential mechanisms of action for postbiotics.
- Synthesis of available data on postbiotic effects.
Main Results:
- Postbiotics may offer novel therapeutic strategies for metabolic diseases.
- Understanding their effects on molecular pathways and the immune system is crucial.
- Further studies are needed to fully elucidate their benefits.
Conclusions:
- Postbiotics are a valuable area for future research in metabolic health.
- Identifying and characterizing new postbiotics can lead to innovative treatments.
- Targeting the gut microbiota with postbiotics shows therapeutic promise.
Related Concept Videos
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Bioremediation
18.3K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
18.3K

